Market News Research Screener Watchlist

HALO Halozyme Therapeutics, Inc.

Healthcare

$68.72+0.59%ClosedMarket Cap: $8.15B

As of 2026-05-26

Overview Financials Analyst Insider Congress ETF & Holdings Dividends Earnings Comments

No congress trading data available for HALO.

Data provided for informational purposes only. Not financial advice.

© 2026 InvestLog AI